0 items USD 0.00Search
Your search for "qyresearch china gliclazide industry 2015 market research report" gave back 321320 results.
Gliclazide is an oral hypoglycemic and is classified as a sulfonylurea. The global Gliclazide market was valued at US$ million in 2023 and is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. The global Gliclazide Reagent market was...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Gliclazide is an oral hypoglycemic and is classified as a sulfonylurea. The global Gliclazide market is projected to grow from US$ million in 2023 to...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. The global Gliclazide Reagent market is...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Gliclazide API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Gliclazide API is used by pharmaceutical companies to develop and manufacture various formulations of the drug, such as tablets, capsules, and...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Gliclazide is an oral hypoglycemic and is classified as a sulfonylurea. The global Gliclazide market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. The global Gliclazide Reagent market was...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Gliclazide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
April 2023
Price: USD 3,660.00
Gliclazide is an oral hypoglycemic and is classified as a sulfonylurea. The “Gliclazide Industry Forecast” looks at past sales and reviews total...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. The “Gliclazide Reagent Industry Forecast...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Gliclazide API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of %...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Gliclazide is an oral hypoglycemic and is classified as a sulfonylurea. According to our Publisher latest study, the global Gliclazide market size...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Gliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. According to our Publisher latest study,...
Catalog:
GIR
February 2023
Price: USD 3,480.00
According to QYResearch’s new survey, global SMBB Ribbon market is projected to reach US$ 1370.2 million in 2029, increasing from US$ 161.7 million...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
